Trial Profile
A Single Randomized, Open,Cross-over, Phase Ig Study to Access the Drug-drug Interaction of SP2086 and Simvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2016
Price :
$35
*
At a glance
- Drugs Retagliptin (Primary) ; Simvastatin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Jiangsu Hengrui Medicine Co.
- 08 Jul 2016 New trial record